04:18 PM EDT, 06/05/2026 (MT Newswires) -- Jade Biosciences ( JBIO ) said late Friday it has closed its public offering of 11.5 million shares, including the full exercise of an over-allotment option, raising $172.5 million for the clinical-stage biotechnology company.

The company said net proceeds will be used among others for clinical trials, preclinical studies, working capital and other general corporate purposes.